Table 2.
Clinical characteristics of hospitalized patients and co morbidities identified in hospitalized patients
| Variable | 222D | 222G/N/V/A | p |
|---|---|---|---|
| Female gender |
33.33% |
66.67% |
0.0884 |
| Age (yrs) |
40.5 (26–50.5) |
39.5 (29.5 - 47.5) |
0.9145 |
| BMI |
30.57 (26.93 - 33.06) |
35.77 (27.69 - 38.02) |
0.359 |
| Evolution time (days) |
7 (4–8) |
4.5 (4–6.5) |
0.2102 |
| Heart rate (bpm) |
110 (84.5 - 120) |
108 (90.5 - 117.5) |
0.8702 |
| Resp Rate |
28 (22–32) |
24 (22–28) |
0.1951 |
| O2 saturation (skin) |
83 (64.5 - 87) |
70 (60–78.5) |
0.0793 |
| O2 saturation (blood) |
84 (68.9 - 88.6) |
73.35 (67.6 - 82.6) |
0.168 |
| fiO2 |
21 (21–28) |
21 (21–76.25) |
0.1668 |
| Kirby score |
192.14 (116.71 - 235.72) |
170.95 (73.5 - 216.43) |
0.2 |
| APACHE II |
9 (7–12) |
8 (6.25 - 11) |
0.6787 |
| SOFA score |
4 (2–7) |
4 (3.25 - 6) |
0.6646 |
| Alkaline phosphatase |
105 (78.25 - 136.75) |
94 (87.5 - 157.5) |
0.5886 |
| Platelets |
183500 (128500–236500) |
130500 (107000–176500) |
0.1275 |
| Albumin |
3.4 (3–3.87) |
2.9 (2.48 - 3.44) |
0.0509 |
| Leukocyte count |
6800 (4650–9150) |
4450 (3300–5050) |
0.0079* |
| Neutrophyl count |
5750 (3700–8460) |
3550 (2700–4300) |
0.0079* |
| lymphocyte count |
795 (500–1050) |
400 (300–500) |
0.031* |
| Hemoglobin |
15.25 (13.3 - 15.85) |
12.65 (10.75 - 13.35) |
0.0017* |
|
Co morbidities |
222D |
222G/N/V/A |
p |
| Obesity |
13.89% |
8.33% |
0.9999 |
| Diabetes mellitus |
40.5 (26–50.5) |
39.5 (29.5 - 47.5) |
0.9145 |
| Systemic arterial hypertension |
5.56% |
33.33% |
0.0278* |
| Asthma |
11.11% |
0% |
0.5597 |
| Pseudomonas Sp. |
8.33% |
0% |
0.5629 |
| Staphylococcus Sp |
11.11% |
8.33% |
0.9999 |
| Other | Acinetobacter baumannii, Klepsiella pneumonie, HIV (2), COPD, pulmonary fibrosis, unspecified mycobacteria | Down syndrome |
Values are medians (interquartile range).
* statistically significant.